中国临床医学2025，Vol.32Issue(2)：183-187,5.DOI:10.12025/j.issn.1008-6358.2025.20250045
良性阵发性位置性眩晕患者不同头位偏斜角度下主观视觉垂直线分析
Analysis of subjective visual vertical test results in patients with benign paroxysmal positional vertigo at different head deflection angles
摘要
Abstract
Objective To analyze the clinical significance of subjective visual vertical(SVV)tests at different head deflection angles in assessing utricle function in patients with benign paroxysmal positional vertigo(BPPV).Methods A total of 61 BPPV patients who were treated at the Hearing Impairment and Vertigo Diagnosis and Treatment Center of Otolaryngology Head and Neck Surgery,Xinhua Hospital,Shanghai Jiao Tong University School of Medicine from August 2022 to May 2023 were retrospectively included,and 29 healthy adults were selected as controls.SVV tests were performed on all research subjects at different head deflection angles:upright head(0°),left head 45°(L45°),right head 45°(R45°).The test results between the two groups were compared.Results SVV absolute value at R45°in BPPV group was lower than that in the control group(P=0.003);there was no significant difference in SVV values at 0°and L45°between the two groups.There was no statistical difference in SVV values at different head deflection angles between the control group and the left BPPV group.SVV absolute value at R45°in right BPPV group was lower than that in the control group(P＜0.001);there was no statistical difference in SVV values at 0°and L45° between the two groups.Conclusions SVV test can provide subjective information about the utricle,and SVV tests at different head deflection angles can fine-tune evaluate the function of the utricle in BPPV patients.关键词
良性阵发性位置性眩晕/主观视觉垂直线/椭圆囊/头位偏斜角度Key words
benign paroxysmal positional vertigo/subjective visual vertical/utricle/head deflection angle分类
临床医学引用本文复制引用
秦茂林,马孝宝,高德坤,沈佳丽,张勤,金玉莲,王节,杨军,陈建勇..良性阵发性位置性眩晕患者不同头位偏斜角度下主观视觉垂直线分析[J].中国临床医学,2025,32(2):183-187,5.基金项目
国家重点研发计划(2024YFC2511100).Supported by National Key R&D Program of China(2024YFC2511100). （2024YFC2511100）
